Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 157 member C (FAM157C) is a long non-coding RNA (lncRNA) that does not encode a protein but is instead involved in regulatory processes at the RNA level[5][3]. FAM157C has been shown to be upregulated in the clonal populations of paroxysmal nocturnal hemoglobinuria (PNH) and contributes to the proliferation of these clones, likely acting as a regulator of genes involved in cell proliferation and survival[3]. Knockdown of FAM157C in PNH cell models leads to reduced proliferation and increased apoptosis, suggesting a role in clonal expansion[3]. FAM157C is also known by the alias LINC02193[5], and it may have broader involvement in disease processes regulated by lncRNAs, including various cancers, although direct disease associations outside of PNH require further study[2][3]. There is currently no evidence that FAM157C is a receptor, enzyme, transporter, or other classical drug target[5][3]. No drugs or direct inhibitors targeting FAM157C are currently known, and it is not established as a clinical biomarker or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 157 member C (FAM157C).